The obtained results confirm the diagnostic accuracy of NF-κB; therefore, its identification in serum seems to be a promising biomarker for the detection of EBV-related oropharyngeal carcinoma. This evidence concerns the gene NFKB1 and oropharyngeal carcinoma.